AU2018234027B2 - Method for producing 3, 6-disubstituted imidazo[1, 2-b]pyridazine derivative - Google Patents

Method for producing 3, 6-disubstituted imidazo[1, 2-b]pyridazine derivative Download PDF

Info

Publication number
AU2018234027B2
AU2018234027B2 AU2018234027A AU2018234027A AU2018234027B2 AU 2018234027 B2 AU2018234027 B2 AU 2018234027B2 AU 2018234027 A AU2018234027 A AU 2018234027A AU 2018234027 A AU2018234027 A AU 2018234027A AU 2018234027 B2 AU2018234027 B2 AU 2018234027B2
Authority
AU
Australia
Prior art keywords
formula
compound represented
salt
palladium
palladium catalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018234027A
Other languages
English (en)
Other versions
AU2018234027A1 (en
Inventor
Yoshifumi HACHISU
Yoshito HAMADA
Takafumi KITAWAKI
Ryoji KOIKE
Shohei SHIRAISHI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of AU2018234027A1 publication Critical patent/AU2018234027A1/en
Application granted granted Critical
Publication of AU2018234027B2 publication Critical patent/AU2018234027B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/14—Adipic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B61/00—Other general methods
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2018234027A 2017-03-14 2018-03-13 Method for producing 3, 6-disubstituted imidazo[1, 2-b]pyridazine derivative Active AU2018234027B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017-049138 2017-03-14
JP2017049138 2017-03-14
PCT/JP2018/009596 WO2018168815A1 (ja) 2017-03-14 2018-03-13 ３，６－ジ置換イミダゾ［１，２－ｂ］ピリダジン誘導体の製造方法

Publications (2)

Publication Number Publication Date
AU2018234027A1 AU2018234027A1 (en) 2019-10-31
AU2018234027B2 true AU2018234027B2 (en) 2021-12-09

Family

ID=63523451

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018234027A Active AU2018234027B2 (en) 2017-03-14 2018-03-13 Method for producing 3, 6-disubstituted imidazo[1, 2-b]pyridazine derivative

Country Status (13)

Country Link
US (3) US11028091B2 (https=)
EP (2) EP3597648B1 (https=)
JP (4) JP7082608B2 (https=)
CN (2) CN110418792B (https=)
AU (1) AU2018234027B2 (https=)
CA (1) CA3055504A1 (https=)
ES (1) ES2947326T3 (https=)
HR (1) HRP20230764T1 (https=)
HU (1) HUE063830T2 (https=)
PL (1) PL3597648T3 (https=)
RS (1) RS64354B1 (https=)
SM (1) SMT202300269T1 (https=)
WO (1) WO2018168815A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE063830T2 (hu) * 2017-03-14 2024-02-28 Daiichi Sankyo Co Ltd Eljárás 3,6-diszubsztituált imidazo[1,2-b]piridazin származék elõállításához
AU2021453749A1 (en) * 2021-07-01 2023-12-21 Nuvation Bio Inc. Crystalline forms of 3-{4-[(2r)-2-aminopropoxy]phenyl}-n-[(1r)- 1-(3-fluorophenyl) ethyl]imidazo[1,2-b]pyridazin-6-amine and salts thereof
US20250326756A1 (en) * 2022-05-18 2025-10-23 Nuvation Bio Inc. Method for producing 3,6-disubstituted-imidazo[1,2-b]pyridazine compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013183578A1 (ja) * 2012-06-04 2013-12-12 第一三共株式会社 キナーゼ阻害剤としてのイミダゾ[１，２－ｂ]ピリダジン誘導体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60197640A (ja) * 1984-03-19 1985-10-07 Ihara Chem Ind Co Ltd ハロゲン化ニトロベンゼン類の製造方法
JPS61205220A (ja) * 1985-03-08 1986-09-11 Rikagaku Kenkyusho 一級アルコ−ル類の選択的フツ素化方法
JP3551493B2 (ja) * 1994-10-21 2004-08-04 三菱化学株式会社 新規ビスオキサゾリン化合物
AU2001260607A1 (en) * 2000-05-24 2001-12-03 Nissan Chemical Industries Ltd. Nitrile compounds and process for their preparation
JP2002193914A (ja) * 2000-05-24 2002-07-10 Nissan Chem Ind Ltd ニトリル化合物およびその製造方法
FR2918061B1 (fr) 2007-06-28 2010-10-22 Sanofi Aventis Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique.
FR2934994B1 (fr) * 2008-08-12 2010-09-17 Sanofi Aventis Derives de 2-alkyl-6cycloamino-3-(pyridin-4-yl)imidaz°1,2-b! pyridazine, leur preparation et leur application en therapeutique
WO2013134219A1 (en) 2012-03-09 2013-09-12 Lexicon Pharmaceuticals, Inc. Imidazo [1, 2 - b] pyridazine - based compounds, compositions comprising them, and uses thereof
JP2016510764A (ja) * 2013-03-07 2016-04-11 カリフィア バイオ, インク.Califia Bio, Inc. 混合系キナーゼ阻害剤および治療法
US9193736B2 (en) * 2013-06-11 2015-11-24 Janssen Pharmaceutica, Nv PDE 10a inhibitors for the treatment of type II diabetes
HUE063830T2 (hu) 2017-03-14 2024-02-28 Daiichi Sankyo Co Ltd Eljárás 3,6-diszubsztituált imidazo[1,2-b]piridazin származék elõállításához
JP7648372B2 (ja) * 2020-11-30 2025-03-18 株式会社ファンケル クロロフィル含有食品用緑色退色抑制剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013183578A1 (ja) * 2012-06-04 2013-12-12 第一三共株式会社 キナーゼ阻害剤としてのイミダゾ[１，２－ｂ]ピリダジン誘導体

Also Published As

Publication number Publication date
AU2018234027A1 (en) 2019-10-31
HUE063830T2 (hu) 2024-02-28
WO2018168815A1 (ja) 2018-09-20
JP7384963B2 (ja) 2023-11-21
JP7082608B2 (ja) 2022-06-08
JP2025123513A (ja) 2025-08-22
EP3597648B1 (en) 2023-06-07
US20210171532A1 (en) 2021-06-10
EP3597648A1 (en) 2020-01-22
US11028091B2 (en) 2021-06-08
PL3597648T3 (pl) 2023-07-24
EP3597648A4 (en) 2020-10-14
US11667642B2 (en) 2023-06-06
JP2023171735A (ja) 2023-12-05
CN114773351A (zh) 2022-07-22
CN110418792B (zh) 2022-07-05
SMT202300269T1 (it) 2023-09-06
EP3597648C0 (en) 2023-06-07
RS64354B1 (sr) 2023-08-31
CA3055504A1 (en) 2018-09-20
ES2947326T3 (es) 2023-08-04
US20200062765A1 (en) 2020-02-27
EP4101853A1 (en) 2022-12-14
JP2022105746A (ja) 2022-07-14
HRP20230764T1 (hr) 2023-10-13
JPWO2018168815A1 (ja) 2020-04-23
US20230227459A1 (en) 2023-07-20
CN110418792A (zh) 2019-11-05

Similar Documents

Publication Publication Date Title
US20230227459A1 (en) Method for producing 3,6-disubstituted-imidazo[1,2-b]pyridazine derivative
WO2023143605A1 (en) Process for the synthesis of pyrazolyl derivatives useful as anti-cancer agents
JP7795485B2 (ja) ピリミジニル－３，８－ジアザビシクロ［３．２．１］オクタニルメタノン誘導体およびその塩の調製
JP2020143070A (ja) ジアリールチオヒダントイン化合物の調製方法
CN115298199A (zh) 环孢菌素衍生物的制备
MX2012009473A (es) Procesos para preparar derivados de ciclopropilamidas e intermedios asociados con estas.
CN113480485B (zh) 一种1,2,4-三芳基-1,2,4-三唑烷类化合物及其合成方法
US10723739B2 (en) Processes for the preparation of Ribociclib and intermediates thereof
CN113200932B (zh) 一种恶唑烷酮的合成方法
CN103402973B (zh) 化合物及其生产方法，以及用于生产磷酸奥司他韦的方法
CN109942446A (zh) 一种普瑞巴林的制备方法
JP2006001882A (ja) Ｏ−置換チロシン化合物の製造方法
CA3185274C (en) Method for producing 1,3-benzodioxole derivative
JP2024173497A (ja) 芳香族シクロアルキルアミン化合物の製造方法
WO2026061642A1 (en) Solid form of methyl 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylate or a salt thereof, method for the preparation thereof, and use thereof in the synthesis of deucravacitinib
CN114853662A (zh) 手性肼基哌啶衍生物的制备方法
CN118324651A (zh) 一种手性酰胺的制备方法及其应用
JPWO2012002203A1 (ja) β−アミノカルボニル化合物の製法
JPH05255166A (ja) α−アミノ酢酸誘導体を経由するアルデヒドの製造方法及びイミニウム塩化合物
WO2003097572A1 (en) 4-alkyl-2-haloaniline derivative and process for producing the same

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO ADD HAMADA, YOSHITO

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ KOIKE, RYOJI; HACHISU, YOSHIFUMI; KITAWAKI, TAKAFUMI; SHIRAISHI, SHOHEI AND HAMADA, YOSHITO